Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis

Pediatric Pulmonology

Volumn 46, Issue 1, 2011, Pages 36-44

  Sawicki, Gregory S ^a   Rasouliyan, Lawrence ^b   McMullen, Ann H ^c   Wagener, Jeffrey S ^d   McColley, Susanna A ^e   Pasta, David J ^b   Quittner, Alexandra L ^f  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ICON CLINICAL RESEARCH   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF MIAMI   (United States)

Author keywords

minority status; national database; patient reported outcomes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY IMAGE; BODY WEIGHT; CHILD; EATING DISORDER; FEMALE; HEALTH STATUS; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; STRUCTURED QUESTIONNAIRE; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSEUDOMONAS INFECTIONS; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY SOUNDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650492873     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21325     Document Type: Article

References (24)

1. Goldbeck L, Zerrer S, Schmitz TG,. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros 2007; 6: 171-178.
2. Goss CH, Quittner AL,. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007; 4: 378-386.
3. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M,. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005; 128: 2347-2354.
4. US Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Center for Biologics Evaluation and Research, US Dept of Health and Human Services, 2009. Available at. http://www.fda.gov/downloads/Drugs/Guidance- ComplianceRegulatoryInformation/Guidances/UCM193282.pdf
5. Gee L, Abbott J, Conway SP, Etherington C, Webb AK,. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros 2003; 2: 206-213.
6. Gee L, Abbott J, Hart A, Conway SP, Etherington C, Webb AK,. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros 2005; 4: 59-66. (Pubitemid 40347779)
7. Yi MS, Tsevat J, Wilmott RW, Kotagal UR, Britto MT,. The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference? J Pediatr 2004; 144: 711-718.
8. Quittner AL, Buu A,. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol 2002; 33: 269-276.
9. Johnson JA, Connolly M, Zuberbuhler P, Brown NE,. Health-related quality of life for adults with cystic fibrosis: a regression approach to assessing the impact of recombinant human DNase. Pharmacotherapy 2000; 20: 1167-1174.
10. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW,. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. J Am Med Assoc 2003; 290: 1749-1756.
11. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC,. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006; 354: 241-250.
12. McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB,. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 921-928.
13. Retsch-Bogart GZ, Burns JL, Otto KL, Liou TG, McCoy K, Oermann C, Gibson RL,. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol 2008; 43: 47-58.
14. Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Light MJ, Rabin HR, Regelmann WE, Schidlow DV, Stokes DC, Wohl ME, Kaplowitz H, Wyatt MM, Stryker S,. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol 1999; 28: 231-241.
15. Modi AC, Quittner AL,. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003; 28: 535-545.
16. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA,. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139.
17. Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB,. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009; 135: 1610-1618.
18. Sawyer MG, Reynolds KE, Couper JJ, French DJ, Kennedy D, Martin J, Staugas R, Ziaian T, Baghurst PA,. Health-related quality of life of children and adolescents with chronic illness-a two year prospective study. Qual Life Res 2004; 13: 1309-1319.
19. Sawyer MG, Reynolds KE, Couper JJ, French DJ, Kennedy D, Martin J, Staugas R, Baghurst PA,. A two-year prospective study of the health-related quality of life of children with chronic illness-the parents' perspective. Qual Life Res 2005; 14: 395-405.
20. Abbott J, Hart A, Morton AM, Dey P, Conway SP, Webb AK,. Can health-related quality of life predict survival in adults with cystic fibrosis? Am J Respir Crit Care Med 2009; 179: 54-58.
21. Abbott J, Hart A, Morton A, Gee L, Conway S,. Health-related quality of life in adults with cystic fibrosis: the role of coping. J Psychosom Res 2008; 64: 149-157.
22. Havermans T, Vreys M, Proesmans M, De Boeck C,. Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child Care Health Dev 2006; 32: 1-7.
23. Sawicki GS, Sellers DE, Robinson WM,. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009; 8: 91-96.
24. Barker DH, Quittner AL,. A biopsychosocial model of CF: social and emotional functioning, adherence and quality of life. In:, Allen J, Panitch H, Rubenstein R, editors. Lung biology in health and disease series: cystic fibrosis. New York: Informa Healthcare, 2010; 468-481.